Syn1 is also upregulated in MCF-7 luminal and MDA-MB-231 triple-negative breast cancer cell lines and about 38% of breast tumor specimens and facilitates the tumor cell fusion with endothelial cells while blocking its expression inhibits the formation of THCs (Bjerregaard et al., 2006). Here, SYN1 is linked to neoplasm.